the data provide no reason to suppose that mdl 72145 would be very different in clinical use from l-deprenyl which is both effective and well-tolerated as an adjunct to the l-dopa-based therapy of parkinson 's disease .
C0023570
l-dopa
C0030567
parkinson 's disease